Literature DB >> 5072432

Role of drug metabolism in drug research and development: pharmaceutical chemistry aspects.

K R Heimlich.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 5072432     DOI: 10.1002/jps.2600611042

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  5 in total

1.  Conformational interconversion of MLKL and disengagement from RIPK3 precede cell death by necroptosis.

Authors:  Sarah E Garnish; Yanxiang Meng; Akiko Koide; Jarrod J Sandow; Eric Denbaum; Annette V Jacobsen; Wayland Yeung; Andre L Samson; Christopher R Horne; Cheree Fitzgibbon; Samuel N Young; Phoebe P C Smith; Andrew I Webb; Emma J Petrie; Joanne M Hildebrand; Natarajan Kannan; Peter E Czabotar; Shohei Koide; James M Murphy
Journal:  Nat Commun       Date:  2021-04-13       Impact factor: 14.919

Review 2.  Programmed Necrosis and Disease:We interrupt your regular programming to bring you necroinflammation.

Authors:  Eui Ho Kim; Sing-Wai Wong; Jennifer Martinez
Journal:  Cell Death Differ       Date:  2018-10-22       Impact factor: 15.828

Review 3.  Pyroptosis versus necroptosis: similarities, differences, and crosstalk.

Authors:  Daniel Frank; James E Vince
Journal:  Cell Death Differ       Date:  2018-10-19       Impact factor: 15.828

Review 4.  The clinical relevance of necroinflammation-highlighting the importance of acute kidney injury and the adrenal glands.

Authors:  Wulf Tonnus; Florian Gembardt; Markus Latk; Simon Parmentier; Christian Hugo; Stefan R Bornstein; Andreas Linkermann
Journal:  Cell Death Differ       Date:  2018-09-17       Impact factor: 15.828

5.  Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation.

Authors:  Lucie Laurien; Masahiro Nagata; Hannah Schünke; Tom Delanghe; Janica L Wiederstein; Snehlata Kumari; Robin Schwarzer; Teresa Corona; Marcus Krüger; Mathieu J M Bertrand; Vangelis Kondylis; Manolis Pasparakis
Journal:  Nat Commun       Date:  2020-04-08       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.